Neuropharmacology Flashcards
1
Q
anti-epileptic drugs
A
- traditional
- diazepam
- phenobarb
- bromide (K or Na)
- Gabapentin
- newer
- zonisamide
- levetiracetam
- pregabalin
- imepitoin
2
Q
indications for anticonvulsants
A
- absolute
- cluster seizures
- status epilepticus
- neurologic deficits or suspicion of structural disease
- aggression pre- or post-ictal
3
Q
status epilepticus
A
- rapidly recurring seizures with incomplete recovery between episodes
- more likely in large breed dogs
- toxins
- metabolic
- sudden drug withdrawal; ineffective drugs
- progressive disease
4
Q
when to load
A
- any clustering
- if >2 seizures in 24 hours
- progressive seizures over time
- suspicion of structural brain dz and active seizures
5
Q
diazepam
A
- emergency
- IV, IN, per rectum
- give up to 3 times
- anticonvulsant effects ~20 min
- no oral diazepam in cat!
6
Q
phenobarbital
A
- long acting barbiturate
- T 1/2 ~40 hrs
- loading
- hepatic metabolism
- IV ~20 minutes to effect in brain
- reaches steady state in 10-14 days
7
Q
phenobarb monitoring
A
- check levels two weeks after starting therapy
- every six months thereafter
- chemistry panel q 6mo
- if concerns, bile acids definitive function test
- will interfere with TT4 and fT4 but does not make them clinically hypothyroid
- will increase ALP
- transient sedation, paraparesis, ataxia
- hepatotoxicity
8
Q
potassium bromide
A
- T 1/2 : ~21 days (15-40)
- maintenance and loading doses
- reaches steady state at about 3 mo
- monitoring levels q6-12 mo
- dietary restrictions (Cl-)
- side effects: bromism
- fatal asthma in cats****
9
Q
gabapentin
A
- poor anticonvulsant (except for rabbits)
- AED dose and pain dose
- main side effect is sedation
10
Q
A
11
Q
novel anticonvulsants
A
- 20-30% epileptic dogs refractory to PB +/- bromide
- Keppra, zonisamide, topiramate
12
Q
Keppra (levetiracetam)
A
- calcium channel blocker, binds SV2a
- T1/2: ~3h
- metabolism: all tissues in the body
- no known significant side effects to date
13
Q
zonisamide
A
- sulfonamide, multiple MOAs
- T1/2 ~15 hours
- reaches steady state in 3-4 days
- hepatically metabolized
- PB increases clearance, so higher doses required
- chem panel and serum level q6h
- side effects
- cats and dogs
14
Q
pregabalin
A
- neuronal voltage-gated Ca channel blocker
- theorectically more effective than gaba
- no PK studies in the dog
15
Q
Topamax
A
- topiramate
- t1/2: ~3-30h
- third line drug
- less expensive
16
Q
felbamate
A
- t1/2: 5-6 hrs
- hepatotoxicity, especially when combined with other potentially hepatotoxic drugs (PB, Zon)
17
Q
drug for control within 24 hours
A
phenobarbital load, Keppra, bromide IV load
18
Q
drug for control within 1 week
A
- phenobarb, zonisamide, Keppra
19
Q
drugs for control within 1 month
A
phenobarbital, zonisamide, Keppra, +/- bromide oral load
20
Q
cluster seizures
A
- >2 seizures in 24 hours
- period of normalcy in between episodes
- reliable pattern of multiple seizures at each event
- doesn’t matter if generalized or partial seizures
- usually require >2 meds for adequate control
21
Q
neurogenic pulmonary edema
A
- non-cardiogenic
- seizures, upper airway obstruction, electrocution
- loss of autonomic vascular tone
- NOT responsive to diuretics
- treat underlying cause-stop the seizures
- oxygen support
22
Q
blood-brain barrier
A
- continuous tight junctions between endothelial cells
- perivascular astrocyte feet
- small pores
- small, lipophyllic compounds can pass
23
Q
infectious organisms
A
- E. coli
- Streptococcus
- Staphylococcus
- Klebsiella
- Pasteurella
- Nocardia
- Actinomyces
- Cryptococcus
- Toxoplasma
- Neospora
24
Q
chemotherapeutics
A
- cyclosporine
- mycophenolate mofetil
- leflonumide
- cytosine arabinoside
- procarbazine
- lomustine CCNU
- L-asparaginase
25
Q
corticosteroids
A
- physiologic vs anti-inflam vs immunosuppressive
- short-acting T1/2 <12h
- cortisone, hydrocortisone
- intermediate T1/2 12-36h
- prednisone, methylprednisone, triamcinolone
- long-acting T1/2 >48h
- paramethasone, flumethasone, dexamethasone, betamethasone
26
Q
types of steroids
A
- effects modified based on ester form
- highly soluble esters (Solu-Medrol, Decadron)
- absorption over minutes to hrs
- moderately insoluble esters (Depo-Medrol)
- absorption over days to weeks
- poorly soluble esters (Vetalog, Gentocin otic)
- released over weeks to months
27
Q
neuroprotective corticosteroids
A
- methylprednisolone sodium succinate
- Solu-Medrol: only corticosteroid to potentially improve outcome in acute spinal cord injury
- must be given w/in 8 hrs of event
- side effects!
- not standard of care
28
Q
reasons for high-dose steroids
A
- prevention of secondary injury
- for acute spinal cord injury
- ischemia, vasospasm, ionic changes, free radical prod, inflam, apoptosis
- MPSS only
- immunosuppression
- for definitively diagnosed CNS inflam disease (GME, other myelitis…)
- corticosteroids +/- other immunomodulants